Japan’s health ministry has issued a warning to consumers regarding red yeast rice dietary supplements containing a red species of mold after 5 people died and more were hospitalized after consumption.
Last month, supplements containing beni koji were pulled off the shelves in Japan after reports came out that they were linked to deaths and hospitalizations. Although the exact reason why remains unknown, health officials are warning consumers everywhere to be wary of supplements containing the ingredient, especially as the supplements were exported to other countries and don’t require a prescription to purchase.
In March, Osaka-based Kobayashi Pharmaceutical Co. faced criticism for its delayed response to a health scare. The company finally announced that 5 people had died and over 100 were hospitalized after taking its cholesterol-lowering supplements containing beni koji, a red species of mold.1 Reports revealed that Kobayashi Pharmaceutical was aware of potential health risks as early as January, raising concerns about the company’s handling of the situation and prompting facility inspections by the Japanese health ministry.2 The supplements were recalled, along with dozens of other products such as miso paste, crackers, and a vinegar dressing that also contained the red mold derivative.3
Kobayashi Pharmaceutical is well established in the beni koji market; in the last 3 fiscal years, the company produced over a million packages of beni koji-containing products.3 But in a news conference earlier this month, company officials said they had found puberulic acid—a chemical compound that may be linked to the fatalities—in its products, which led to the supplements’ pull off the shelves.1 Notably, many people who died or were hospitalized experienced kidney complications. However, the company said it “cannot rule out” the unintended ingredient that had caused an adverse effect when combined with other ingredients.4
The company also revealed that it had exported its products to other countries, including China and Taiwan.1 While no US products have been recalled yet, consumers everywhere should be cautious of supplements containing beni koji.
Many consumers assume that like OTC or prescription drugs, dietary supplements are vetted by the FDA. Contrary to this belief, dietary supplements lie outside of the FDA’s scope of verification.1 Rather, supplement manufacturers are the ones responsible for ensuring the safety and effectiveness of their products. Although federal law sets regulations for supplements, they are less strict compared to those for pharmaceuticals.
READ MORE: Cardiology Resource Center
GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status
October 1st 2024Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.